Lead sponsor
Otsuka Pharmaceutical Co., Ltd.
3 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
3
Trials led
1
Ongoing
774
Total enrollment
2
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2/3
1
Phase 3
1
Not applicable
1
Trials by status
Recruiting
1
Completed
2
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's TypeAlzheimer's diseasePh 2/3Completed410